Search results | nutrition

Reports

Nutrition & Vitamins Partnering

Nutrition & Vitamins Partnering provides understanding and access to the nutrition & vitamins partnering deals and agreements entered into by the worlds leading healthcare companies

Insights

Pharma deals update: Nestle gains nutrition business from Pfizer for $11.85 billion

The world’s biggest food company and the world’s biggest drug company have agreed in $11.85 billion pharma deals agreement  where Pfizer’s infant nutrition business has moved over the Nestle, edging out Danone in the process

Reuters: Nestle leads pack of bidders for Pfizer nutrition unit

Written by David Jones for Reuters. Swiss food group Nestle is in pole position to buy Pfizer’s $10 billion Wyeth infant nutrition business in a two-horse race with French rival Danone and so boost its fast-growing Chinese business.

Pfizer readies bidding info for nutritionals auction

Pfizer plans to send out information on its infant-nutrition unit to potential bidders in September, kicking off an auction that may fetch as much as $10.5 billion, said people with knowledge of the process.

Aspen Pharmacare – Africa’s biggest generic drugmaker

Aspen Pharmacare specialises in the production of branded and generic pharmaceuticals and is currently the biggest pharmaceutical company in South Africa taking a 15% share of the total market.

Top 15 most partnered therapeutic trends in pharma industry

Current Partnering releases its first update of the article previously published last year on the most partnered therapeutic trends in pharma. The article analyses the most partnered therapeutic targets of 2009-2014 and identifies the areas that have gained in popularity since last year and the new areas that have entered the list

Ranbaxy

Ranbaxy Laboratories is a top pharmaceutical company based in Haryana, India

Grifols

Grifols is a top pharmaceutical company based in Barcelona, Spain.

Abbott Laboratories

Abbott Laboratories is a top pharmaceutical company based in Illinois, USA

Pfizer

Pfizer is a top pharmaceutical company based in New York, USA

Bayer Healthcare

Bayer is a top pharmaceutical company based in Leverkusen, Germany

Events

Sorry, your search returned no results.


Deals

M&A :Reckitt Benckiser acquires Schiff Nutrition for $1.4 billion

Reckitt Benckiser Group has signed a definitive m&a agreement with Schiff Nutrition International.

M&A Deals: Bayer acquires Schiff Nutrition International for an agreed $1.2 billion

Germany’s Bayer, a top name in the pharma circle is set buy U.S. vitamins maker Schiff Nutrition International for an agreed $1.2 billion in a m&a agreement,  as it seeks stable sources of growth to complement its more volatile prescription drugs business

DSM’s M&A deal with Ocean Nutrition Canada for $543 million

In a M&A deal, Royal DSM has successfully completed the acquisition of Ocean Nutrition Canada, the leading global provider of fish-oil derived nutritional products to the dietary supplement and food and beverage markets worldwide.

Nestle acquires Pfizer’s nutrition business for $11.85 billion

Pfizer gets $11.85B in nutrition sale to Nestlé

Reuters: Nestle leads pack of bidders for Pfizer nutrition unit

Written by David Jones for Reuters. Swiss food group Nestle is in pole position to buy Pfizer’s $10 billion Wyeth infant nutrition business in a two-horse race with French rival Danone and so boost its fast-growing Chinese business.

Abbott Laboratories and University of Illinois establish centre for nutrition, learning and memory

Abbott and the University of Illinois at Urbana-Champaign have established the first-ever multi-disciplinary nutrition and cognition research center, which will be located on the Urbana campus.

Jennewein Biotechnologie and Pfizer Nutrition collaborate on human milk components

Jennewein Biotechnologie has signed a license agreement with Pfizer Nutrition to develop and market two Human Milk Oligosaccharides (HMOs).

Pfizer readies bidding info for nutritionals auction

Pfizer plans to send out information on its infant-nutrition unit to potential bidders in September, kicking off an auction that may fetch as much as $10.5 billion, said people with knowledge of the process.

GSK nabs Maxinutrition; Reckitt pays $726M for Paras

A couple of consumer-health deals underscore pharma’s ongoing rush to diversify. First, GlaxoSmithKline ($GSK) has bought a protein-drinks firm, Maxinutrition, for 162 million pounds ($255.7 million), to help complement its nutritional drinks businesses.

Abbott to acquire nutrition businesses for US$130 million

Abbott announced a definitive agreement to acquire the nutrition businesses of Wockhardt Limited, Carol Info Services Limited, and certain Wockhardt subsidiaries and group companies for consideration totaling approximately US$130 million in cash.